Caitong International Asset Management Co., LTD Arrowhead Pharmaceuticals, Inc. Transaction History
Caitong International Asset Management Co., LTD
- $134 Billion
- Q1 2025
A detailed history of Caitong International Asset Management Co., LTD transactions in Arrowhead Pharmaceuticals, Inc. stock. As of the latest transaction made, Caitong International Asset Management Co., LTD holds 1,300 shares of ARWR stock, worth $20,903. This represents 0.01% of its overall portfolio holdings.
Number of Shares
1,300
Previous 2,464
47.24%
Holding current value
$20,903
Previous $46.3 Million
64.25%
% of portfolio
0.01%
Previous 0.05%
Shares
2 transactions
Others Institutions Holding ARWR
# of Institutions
300Shares Held
98MCall Options Held
306KPut Options Held
432K-
Black Rock Inc. New York, NY15.7MShares$252 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA13.2MShares$212 Million0.0% of portfolio
-
Avoro Capital Advisors LLC New York, NY11.1MShares$179 Million2.29% of portfolio
-
State Street Corp Boston, MA7MShares$113 Million0.0% of portfolio
-
Slate Path Capital LP New York, NY5.23MShares$84.1 Million1.32% of portfolio
About ARROWHEAD PHARMACEUTICALS, INC.
- Ticker ARWR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 105,849,000
- Market Cap $1.7B
- Description
- Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. The company's products in pipeline includes ARO-AAT, a RNA interference (RNAi) therapeutic candidate that is in Phase II clinical trial for the treatment of liver diseases associated with alpha-1 antitrypsin deficiency; ARO-APOC3, w...